TY - JOUR
T1 - Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus
AU - Bloch, Olga
AU - Amit-vazina, Mirit
AU - Yona, Eli
AU - Molad, Yair
AU - Rapoport, Micha J.
PY - 2014/6
Y1 - 2014/6
N2 - Objective: The activities of two mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), correlate with disease severity in SLE patients. Whether they are also associated with long-term organ damage is unknown. The aim of the present work was to determine whether impaired expression and activity of ERK and JNK correlate with long-term damage in SLE. Methods: The expression of ERK and JNK and their phosphorylated active forms was determined by western blot analysis four times during the first year of follow-up in peripheral blood mononuclear cells from 36 SLE patients. A correlation analysis was performed between ERK and JNK expression and long-term organ damage estimated by the SLICC/ARC Damage Index (SDI) 4 years later. Results: Mean levels of ERK and JNK activities during the first year correlated with long-term organ damage severity (r = 0.38 and r = 0.35, respectively; P = 0.05). Overall JNK expression increased with the severity of chronic damage (P = 0.01; P = 0.05 for SDI score 2 and 3, respectively). In contrast, overall ERK expression significantly decreased in patients with maximal organ damage (SDI score 3) compared with patients with an SDI score of 2 (P = 0.03). The ERK/JNK ratio decreased by approximately 40% and 30% in patients with an SDI score of 3 as compared with patients without organ damage and healthy controls, respectively. Conclusion: These results demonstrate that early activation of ERK and JNK along with decreased overall ERK expression and reduced ERK/JNK ratio may predict the severity of long-term organ damage in SLE patients.
AB - Objective: The activities of two mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), correlate with disease severity in SLE patients. Whether they are also associated with long-term organ damage is unknown. The aim of the present work was to determine whether impaired expression and activity of ERK and JNK correlate with long-term damage in SLE. Methods: The expression of ERK and JNK and their phosphorylated active forms was determined by western blot analysis four times during the first year of follow-up in peripheral blood mononuclear cells from 36 SLE patients. A correlation analysis was performed between ERK and JNK expression and long-term organ damage estimated by the SLICC/ARC Damage Index (SDI) 4 years later. Results: Mean levels of ERK and JNK activities during the first year correlated with long-term organ damage severity (r = 0.38 and r = 0.35, respectively; P = 0.05). Overall JNK expression increased with the severity of chronic damage (P = 0.01; P = 0.05 for SDI score 2 and 3, respectively). In contrast, overall ERK expression significantly decreased in patients with maximal organ damage (SDI score 3) compared with patients with an SDI score of 2 (P = 0.03). The ERK/JNK ratio decreased by approximately 40% and 30% in patients with an SDI score of 3 as compared with patients without organ damage and healthy controls, respectively. Conclusion: These results demonstrate that early activation of ERK and JNK along with decreased overall ERK expression and reduced ERK/JNK ratio may predict the severity of long-term organ damage in SLE patients.
KW - C-Jun N-terminal kinase
KW - Extracellular signal-regulated kinase
KW - Long-term organ damage
KW - SLEDAI
KW - SLICC/ARC damage index
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=84900792671&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/ket482
DO - 10.1093/rheumatology/ket482
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24501249
AN - SCOPUS:84900792671
SN - 1462-0324
VL - 53
SP - 1034
EP - 1042
JO - Rheumatology
JF - Rheumatology
IS - 6
M1 - ket482
ER -